Literature DB >> 32454589

Antibiotic Resistance Profiles and Genotypes of Acinetobacter baumannii Isolates and In Vitro Interactions of Various Antibiotics in Combination with Tigecycline and Colistin.

Ayça Büyük1, Fethiye Ferda Yilmaz1, Süreyya Gül Yurtsever2, Mine Hoşgör Limoncu1.   

Abstract

OBJECTIVES: The aim of this study was to determine the antibiotic resistance profile, clonal relation and efficacy of antibiotic combinations in nosocomial multidrug resistant (MDR) Acinetobacter baumannii.
MATERIALS AND METHODS: Antibiotic susceptibilities of 84 MDR A. baumannii against tigecycline (TGC), colistin (CL), amikacin (AK), ciprofloxacin (CIP), meropenem (MR), moxifloxacin (MXF), rifampicin (RF) were determined by microdilution method. Clonal relationship was investigated by genotyping using AP-PCR and antibiotyping. Interactions of antibiotic combinations were tested against clonally unrelated strains by the checkerboard (CB) method. The efficacy of the best combinations was also assesed on a selected isolate by the time-kill (TK) method.
RESULTS: CIP, RF, MXF, MR, AK resistance was found as 90.47%; 47.62%; 22.62%; 58.33%; 50% respectively; however; CL and TGC were not ascertained. The isolates were distinguished as 25 different antibiotypes and 15 varied molecular patterns. The best synergistic effect was detected in combinations of CL with RF (100%) and MR (100%), in combinations of TGC with RF (53%) against clonally unrelated 15 MDR A. baumannii isolates by the CB method. While CL-RF and CL-MR showed synergy by TK method like CB, on the other hand TGC-RF indicated additive interactions by TK.
CONCLUSION: In this study, both synergy tests showed that CL in combination with RF would be a good option in MDR A. baumannii. ©Copyright 2017 Turk J Pharm Sci, Published by Galenos Publishing House.

Entities:  

Keywords:  AP-PCR; Acinetobacter; checkerboard; colistin; tigecycline; time-kill

Year:  2017        PMID: 32454589      PMCID: PMC7228003          DOI: 10.4274/tjps.44127

Source DB:  PubMed          Journal:  Turk J Pharm Sci        ISSN: 1304-530X


  22 in total

1.  In vitro antibiotic synergy in extensively drug-resistant Acinetobacter baumannii: the effect of testing by time-kill, checkerboard, and Etest methods.

Authors:  Thean Yen Tan; Tze Peng Lim; Winnie Hui Ling Lee; Suranthran Sasikala; Li Yang Hsu; Andrea Lay-Hoon Kwa
Journal:  Antimicrob Agents Chemother       Date:  2010-10-18       Impact factor: 5.191

2.  Epidemiological investigation of nosocomial Acinetobacter infections using arbitrarily primed PCR & pulse field gel electrophoresis.

Authors:  K Prashanth; S Badrinath
Journal:  Indian J Med Res       Date:  2005-11       Impact factor: 2.375

3.  In vitro synergy of colistin combinations against colistin-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae isolates.

Authors:  Céline Vidaillac; Lothaire Benichou; Raphaël E Duval
Journal:  Antimicrob Agents Chemother       Date:  2012-07-02       Impact factor: 5.191

4.  Synergistic activity of colistin and rifampin combination against multidrug-resistant Acinetobacter baumannii in an in vitro pharmacokinetic/pharmacodynamic model.

Authors:  Hee Ji Lee; Phillip J Bergen; Jurgen B Bulitta; Brian Tsuji; Alan Forrest; Roger L Nation; Jian Li
Journal:  Antimicrob Agents Chemother       Date:  2013-05-28       Impact factor: 5.191

5.  Bacteriological, clinical and epidemiological characteristics of hospital-acquired Acinetobacter baumannii infection in a teaching hospital.

Authors:  M Ayan; R Durmaz; E Aktas; B Durmaz
Journal:  J Hosp Infect       Date:  2003-05       Impact factor: 3.926

6.  A comparative study of different PCR-based DNA fingerprinting techniques for typing of the Acinetobacter calcoaceticus-A. baumannii complex.

Authors:  J Vila; M A Marcos; M T Jimenez de Anta
Journal:  J Med Microbiol       Date:  1996-06       Impact factor: 2.472

7.  In vitro pharmacodynamics of polymyxin B and tigecycline alone and in combination against carbapenem-resistant Acinetobacter baumannii.

Authors:  Mao Hagihara; Seth T Housman; David P Nicolau; Joseph L Kuti
Journal:  Antimicrob Agents Chemother       Date:  2013-11-25       Impact factor: 5.191

8.  In-vitro activity of polymyxin B, rifampicin, tigecycline alone and in combination against carbapenem-resistant Acinetobacter baumannii in Singapore.

Authors:  Tze-Peng Lim; Thean-Yen Tan; Winnie Lee; S Sasikala; Thuan-Tong Tan; Li-Yang Hsu; Andrea L Kwa
Journal:  PLoS One       Date:  2011-04-21       Impact factor: 3.240

9.  In vitro synergism of combinations of colistin with selected antibiotics against colistin-resistant Acinetobacter baumannii.

Authors:  Duygu Percin; Selcan Akyol; Gamze Kalin
Journal:  GMS Hyg Infect Control       Date:  2014-08-19

10.  In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii.

Authors:  Luigi Principe; Silvia D'Arezzo; Alessandro Capone; Nicola Petrosillo; Paolo Visca
Journal:  Ann Clin Microbiol Antimicrob       Date:  2009-05-21       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.